Clinical Trials
3 trialsNCT04983901 2026-04-06
PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN
M.D. Anderson Cancer Center
Phase 2 Completed
NCT03485950 2022-03-15
Comparative Study To Determine The Efficacy, Safety, And Tolerability Of Ceftolozane-Tazobactam
M.D. Anderson Cancer Center
Phase 2 Completed
NCT02149329 2019-09-25
SHORT
Amsterdam UMC, location VUmc
Phase 4 Completed